Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density

Journal of Molecular Endocrinology

Volumn 47, Issue 3, 2011, Pages 327-333

  Vidal, Christopher ^a   Formosa, Robert ^a   Xuereb Anastasi, Angela ^a  

^a UNIVERSITY OF MALTA   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CELL STRAIN COS7; CELL STRAIN RAW264.7; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; FRACTURE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE PRODUCT; HELA CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; TNFRSF11B GENE;

ADULT; AGED; BASE SEQUENCE; BONE DENSITY; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RISK; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER;

EID: 84856330183     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0067     Document Type: Article

References (26)

1. Atkins GJ, Welldon KJ, Halbout P & Findlay DM 2009 Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporosis International 20 653-664. (doi:10.1007/ s00198-008-0728-6)
2. Boyle WJ, Simonet WS & Lacey DL 2003 Osteoclast differentiation and activation. Nature 423 337-342. (doi:10.1038/nature01658)
3. Brandstrom H, Gerdhem P, Stiger F, Obrant KJ, Melhus H, Ljunggren O, Kindmark A & Akesson K 2004 Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly people. Calcified Tissue International 74 18-24. (doi:10.1007/s00223-002-2136-9)
4. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M et al. 2002 A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Human Molecular Genetics 11 2119-2127. (doi:10.1093/hmg/11.18.2119)
5. Fili S, Karalaki M & Schaller B 2009 Therapeutic implications of osteoprotegerin. Cancer Cell International 9 26. (doi:10.1186/1475-2867-9-26)
6. Fonseca JE 2008 Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength. Rheumatology 47 (Supplement 4) iv17-iv19. (doi:10.1093/rheumatology/ ken165)
7. García-Unzueta MT, Riancho JA, Zarrabeitia MT, Sañudo C, Berja A, Valero C, Pesquera C, Paule B, González-Macías J & Amado JA 2008 Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. Hormone andMetabolic Research 40 219-224. (doi:10.1055/s-2008-1046793)
8. Hagedorn C, Telgmann R, Dördelmann C, Schmitz B, Hasenkamp S, Cambien F, Paul M, Brand E & Brand-Herrmann SM 2009 Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter. Arteriosclerosis, Thrombosis, and Vascular Biology 10 1638-1643. (doi:10.1161/ATVBAHA. 109.193532)
9. Hanada R, Hanada T, Sigl V, Schramek D & Penninger JM 2011 RANKL/RANK-beyond bones. Journal of Molecular Medicine 89 647-656. (doi:10.1007/s00109-011-0749-z)
10. Hofbauer LC & Schoppet M 2002 Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease. Journal of Clinical Endocrinology and Metabolism 87 4078-4079. (doi:10.1210/jc.2002-021063)
11. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ & Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone and Mineral Research 15 2-12. (doi:10.1359/jbmr.2000.15.1.2)
12. Jurado S, Nogués X, Agueda L, Garcia-Giralt N, Urreizti R, Yoskovitz G, Pérez-Edo L, Saló G, Carreras R, Mellibovsky L et al. 2010 Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. Osteoporosis International 21 287-296. (doi:10.1007/s00198-009-0956-4)
13. Liu JM, Zhang MJ, Zhao L, Cui B, Li ZB, Zhao HY, Sun LH, Tao B, Li M & Ning G 2010 Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. Journal of Clinical Endocrinology and Metabolism 95 E112-E120. (doi:10.1210/jc.2009-2768)
14. Mencej S, Albagha OME, Prezelj J, Kocjan T & Marc J 2008 Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis. Journal of Molecular Endocrinology 40 273-279. (doi:10.1677/JME-08-0003)
15. Park OJ, Shin SY, Choi Y, Kim MH, Chung CP, Ku Y & Kim KK 2008 The association of osteoprotegerin gene polymorphisms with periodontitis. Oral Disease 14 440-444. (doi:10.1111/j.1601-0825.2007. 01398.x)
16. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR et al. 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371 1505-1512. (doi:10. 1016/S0140-6736(08)60599-1)
17. Roshandel D, Holliday KL, Pye SR, Boonen S, Borghs H, Vanderschueren D, Huhtaniemi IT, Adams JE, Ward KA, Bartfai G et al. 2010 Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. Journal of Bone and Mineral Research 25 1830-1838. (doi:10. 1002/jbmr.78)
18. Santini D, Perrone G, Roato I, Godio L, Pantano F, Grasso D, Russo A, Vincenzi B, Fratto ME, Sabbatini R et al. 2011 Expression pattern of receptor activator of NFkB (RANK) in a series of primary solid tumors and related bone metastases. Journal of Cellular Physiology 226 780-784. (doi:10.1002/jcp.22402)
19. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TVet al. 2008 Multiple genetic loci for bone mineral density and fractures. New England Journal of Medicine 358 2355-2365. (doi:10.1056/NEJMoa0801197)
20. Tan W, Wu H, Zhao J, Derber LA, Lee DM, Shadick NA, Conn DL, Smith EA, Gersuk VH, Nepom GT et al. 2010 A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis. Arthritis and Rheumatism 62 2864-2875. (doi:10.1002/art. 27589)
21. Terwillinger JD & Ott J 1994 Linkage disequilibrium between alleles at marker loci. In Handbook of Human Genetic Linkage, pp 188-198. Baltimore: John Hopkins University Press.
22. Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A & Prince RL 2007 No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone 40 175-181. (doi:10.1016/j.bone. 2006.06.022)
23. Vidal C, Brincat M& Xuereb Anastasi A 2006 TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas 53 386-395. (doi:10.1016/j.maturitas.2005.11.003)
24. Vidal C, Cachia A & Xuereb-Anastasi A 2009 Effects of a synonymous variant in exon 9 of the CD44 gene on pre-mRNA splicing in a family with osteoporosis. Bone 45 736-742. (doi:10.1016/j.bone.2009.06. 027)
25. Whyte MP 2006 Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB. Annals of the New York Academy of Sciences 1068 143-164. (doi:10.1196/annals.1346.016)
26. Xu XH, Dong SS, Guo Y, Yang TL, Lei SF, Papasian CJ, ZhaoM& Deng HW 2009 Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocrine Reviews 31 447-505. (doi:10.1210/er.2009-0032)